Turmeric, oleoresin (curcumin): Target Organs and Levels of Evidence for TR-427
Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CASRN 8024-37-1) (Major Component 79% Curcumin, CASRN 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies)
Chemical (Study Title)
CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|
Turmeric, oleoresin (curcumin)
8024-37-1 | 06/23/1992 | Dosed-Feed
R & M: 0, .2, 1.0, AND 5.0% | T.S.I. Mason Laboratories, Inc. |
Levels of Evidence
Male Rats: No Evidence
| Type | Organ/Tissue (Lesion) |
|---|
| Non-Neoplastic Lesions | - FORESTOMACH: ULCER; HYPERPLASIA; HYPERKERATOSIS
- INTESTINES: ULCER; HYPERPLASIA; INFLAMMATION
- LYMPH NODE: (MESENTERIC) SINUS ECTASIA
|
Female Rats: Equivocal Evidence
| Type | Organ/Tissue (Lesion) |
|---|
| Neoplastic Lesions | - Clitoral Gland:
ADENOMA 5/50 12/48 15/47 16/49 OR CARCINOMA 1/50 4/48 0/47 0/49 COMBINED 6/50 16/48 15/47 16/49
|
| Non-Neoplastic Lesions | - INTESTINES: ULCER; HYPERPLASIA; INFLAMMATION
- LYMPH NODE: (MESENTERIC) SINUS ECTASIA
|
Male Mice: Equivocal Evidence
| Type | Organ/Tissue (Lesion) |
|---|
| Neoplastic Lesions | - Liver:
ADENOMA 25/50 28/50 35/50 30/50 OR CARCINOMA 12/50 18/50 16/50 18/50 COMBINED 30/50 38/50 41/50 37/50
- Intestines:
CARCINOMA 0/50 3/50 3/50 0/50
|
Female Mice: Equivocal Evidence
| Type | Organ/Tissue (Lesion) |
|---|
| Neoplastic Lesions | - Liver:
ADENOMA 7/50 8/50 19/51 14/50 OR CARCINOMA 7/50 5/50 10/51 6/50 COMBINED 13/50 12/50 25/51 19/50
|
| Non-Neoplastic Lesions | - THYROID GLAND: FOLLICULAR CELL HYPERPLASIA
|
